Achieve Life Sciences (ACHV) Announces Patent Granted in U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: ACHV) | Delayed: 6.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.51 | 52 Week High | $ | |||
| Open | $6.39 | 52 Week Low | $ | |||
| Day High | $6.64 | P/E | N/A | |||
| Day Low | $6.33 | EPS | $ | |||
| Volume | 375,248 | |||||
